Toxicity profile of enfortumab vedotin with or without pembrolizumab in patients with metastatic urothelial carcinoma: A systematic review and meta-analysis.

Authors: Clara Aleixo Simões, Nicole Asbeg, Ana Clara Felix De Farias Santos, Deivyd Cavalcante, Ana Carolina Ventura de Santana de Jesus, Gabriela Gazzoni, Carlos Stecca

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e16567

Source: Full article

---

Abstract

e16567